Elad I Levy is an American neurosurgeon who played a role in the development and testing of thrombectomy, which improved quality of life and survival of stroke patients.
23 Facts About Elad Levy
Elad Levy has focused his career and research on developing evidence based medicine and literature showing the benefits of thrombectomy for the treatment of stroke.
Elad Levy is Professor of Neurosurgery and Radiology, and the L Nelson Hopkins, MD Professor Endowed Chair of the Department of Neurosurgery at the State University of New York at Buffalo.
Elad Levy served as the president for the Congress of Neurological Surgeons annual scientific meeting in September 2023.
Elad Levy is the Director of Stroke Research and Director of Endovascular Stroke Treatment and Research at the Department of Neurosurgery, SUNY at Buffalo, co-director of Kaleida Health Stroke Center at the Gates Vascular Institute, and co-director of Cerebrovascular Surgery at the Department of Neurosurgery, SUNY at Buffalo.
In 2020 Elad Levy received his appointment as Distinguished Professor at the State University of New York at Buffalo due to his contributions to research, innovation, leadership and academia.
Elad Levy served as the neurosurgery consultant for season 2 and season 3 of TV show Grey's Anatomy.
Elad Levy was born in Tiberias, Israel in 1972 where he lived with his parents and grandparents.
Elad Levy's father went to medical school in Italy, where Levy learned to speak Italian, in addition to English in school and Hebrew at home.
Elad Levy attended local schools before his last two years of High School, which he spent at Choate Rosemary Hall, a private boarding school in Wallingford, Connecticut.
Elad Levy went to Dartmouth College to study molecular biology and biochemistry.
Elad Levy completed his fellowship training in 2003 and returned to Pittsburgh to finish his residency training in 2004.
Elad Levy started his academic and professional career as an associate professor of neurosurgery and radiology at the State University of New York at Buffalo in 2004.
Elad Levy was appointed as co-director of Kaleida Health Stroke Center and the Director of Endovascular Stroke Treatment and Research in 2006.
Elad Levy served as the Endovascular Fellowship Program Director for the Department of Neurosurgery, SUNY at Buffalo from 2006 to 2013.
In 2010, Elad Levy was promoted to the title of Professor of Neurosurgery and Radiology.
From 2017 to 2023 Elad Levy served as the director of the American Board of Neurological Surgeons and from 2022 to 2023 he served as the Vice Chair of the American Board of Neurological Surgeons Elad Levy championed the pathway for ABNS board certification for exemplary internationally trained neurosurgeons.
Elad Levy has published and lectured on the endovascular techniques for cerebrovascular disorders, publishing over 600 peer-reviewed publications and more than 200 book chapters, including his latest book titled "Video Atlas of Acute Ischemic Stroke Intervention".
Elad Levy has contributed several live cases for national and international meetings as well as for community education.
Elad Levy was the US Interventional Principal Investigator for the SWIFT PRIME trials.
Elad Levy is the Principal investigator for the COMMAND trial and in 2023 he became the first surgeon to implant the stentrode, a novel stent in that is used for brain computer interface to help patients with limited mobility to operate technology such as mobile devices and computers using their thoughts helping these patients gain back independence.
Elad Levy has published on neurovascular diseases including this three part series highlighting decision-making and providing video examples of complex neurovascular procedures and stroke intervention techniques.
Elad Levy has edited numerous books on neurovascular diseases outlined below.